These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35644085)

  • 41. Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess.
    Biermasz NR; van Thiel SW; Pereira AM; Hoftijzer HC; van Hemert AM; Smit JW; Romijn JA; Roelfsema F
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5369-76. PubMed ID: 15531483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validation of Acromegaly Quality of Life Questionnaire (AcroQoL) for the Iranian population.
    Danaei M; Bahadorizadeh L; Dehnad A; Mohamadzadeh S; Hashemi-Madani N; Khamseh ME
    BMC Psychol; 2022 Mar; 10(1):63. PubMed ID: 35287723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality of life in patients with acromegaly receiving lanreotide autogel: a real-world observational study.
    Bolanowski M; Hubalewska-Dydejczyk A; Kos-Kudła B; Ruchała M; Witek P; Zgliczyński W; Houchard A; Bartmańska M
    Endokrynol Pol; 2021; 72(5):512-519. PubMed ID: 34647602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The quality of life in acromegalic patients with biochemical remission by surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy, using the newly developed Japanese version of the AcroQoL.
    Yoshida K; Fukuoka H; Matsumoto R; Bando H; Suda K; Nishizawa H; Iguchi G; Ogawa W; Webb SM; Takahashi Y
    Pituitary; 2015 Dec; 18(6):876-83. PubMed ID: 26123761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of growth hormone receptor antagonism and somatostatin analog administration on quality of life in acromegaly.
    Dichtel LE; Kimball A; Yuen KCJ; Woodmansee W; Haines MS; Guan QX; Swearingen B; Nachtigall LB; Tritos NA; Sharpless JL; Kaiser UB; Gerweck AV; Miller KK
    Clin Endocrinol (Oxf); 2021 Jan; 94(1):58-65. PubMed ID: 32779234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlations of clinical parameters with quality of life in patients with acromegaly: Taiwan Acromegaly Registry.
    Tseng FY; Chen ST; Chen JF; Huang TS; Lin JD; Wang PW; Huey-Herng Sheu W; Chang TC;
    J Formos Med Assoc; 2019 Nov; 118(11):1488-1493. PubMed ID: 31147197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Questionnaire and tools: clinical powerful instrument in acromegaly diagnosis and management.
    Camerini S; Wennberg A; Adriani M; Martin B; Vettor R; Maffei P; Dassie F
    J Endocrinol Invest; 2022 Oct; 45(10):1823-1834. PubMed ID: 35322391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The self-assessment INTERMED predicts healthcare and social costs of orthopaedic trauma patients with persistent impairments.
    Burrus C; Vuistiner P; Léger B; Stiefel F; Rivier G; Luthi F
    Clin Rehabil; 2021 Jan; 35(1):135-144. PubMed ID: 32851861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in quality of life in patients with acromegaly after surgical remission - A prospective study using SF-36 questionnaire.
    Fujio S; Arimura H; Hirano H; Habu M; Bohara M; Moinuddin FM; Kinoshita Y; Arita K
    Endocr J; 2017 Jan; 64(1):27-38. PubMed ID: 27681883
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Translation and Cross-Cultural Adaptation of the Japanese Version of the INTERMED Self-Assessment Questionnaire (IMSA) for Patient-Case Complexity Assessment.
    Yokokawa D; Shikino K; Kishi Y; Ikusaka M
    Int J Gen Med; 2022; 15():6309-6313. PubMed ID: 35924175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Soluble Klotho: a possible predictor of quality of life in acromegaly patients.
    Coopmans EC; El-Sayed N; Frystyk J; Magnusson NE; Jørgensen JOL; van der Lely AJ; Janssen JAMJL; Muhammad A; Neggers SJCMM
    Endocrine; 2020 Jul; 69(1):165-174. PubMed ID: 32333268
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Morphometric changes correlate with poor psychological outcomes in patients with acromegaly.
    Imran SA; Tiemensma J; Kaiser SM; Vallis M; Doucette S; Abidi E; Yip CE; De Tugwell B; Siddiqi F; Clarke DB
    Eur J Endocrinol; 2016 Jan; 174(1):41-50. PubMed ID: 26586838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgically treated acromegaly patients have a similar quality of life whether controlled by surgery or requiring additional medical therapy (QuaLAT Study).
    Arshad MF; Ogunleye O; Ross R; Debono M
    Pituitary; 2021 Oct; 24(5):768-777. PubMed ID: 33982222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Effect of Aging on Quality of Life in Acromegaly Patients Under Treatment.
    Yamamoto N; Urai S; Fukuoka H; Yamamoto M; Yoshida K; Suzuki M; Shichi H; Fujita Y; Kanie K; Iguchi G; Takahashi Y; Ogawa W
    Front Endocrinol (Lausanne); 2022; 13():819330. PubMed ID: 35185799
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biopsychosocial complexity in functional neurological disorder.
    Joos A; Herrmann C; Lahmann C; Flottman M; Jansen T; Schede C; Maner P; Schörner K; von Husen DK; Jöbges M; Hartmann A
    Gen Hosp Psychiatry; 2023; 84():44-46. PubMed ID: 37379722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegaly.
    Bernabéu I; Fajardo C; Marazuela M; Cordido F; Venegas EM; de Pablos-Velasco P; Maroto GP; Olvera MP; de Paz IP; Carvalho D; Romero C; De la Cruz G; Escolá CÁ
    Endocrine; 2020 Dec; 70(3):575-583. PubMed ID: 32725444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality of Life in Patients with Acromegaly - A Romanian Single Center Cross-Sectional Study.
    Scânteie CL; Leucuţa DC; Ghervan CMV
    Acta Endocrinol (Buchar); 2021; 17(1):42-50. PubMed ID: 34539909
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical Parameters.
    Geraedts VJ; Andela CD; Stalla GK; Pereira AM; van Furth WR; Sievers C; Biermasz NR
    Front Endocrinol (Lausanne); 2017; 8():40. PubMed ID: 28316591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physical exercise improves functional capacity and quality of life in patients with acromegaly: a 12-week follow-up study.
    Lima TRL; Kasuki L; Gadelha M; Lopes AJ
    Endocrine; 2019 Nov; 66(2):301-309. PubMed ID: 31317523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improvement in Symptoms and Health-Related Quality of Life in Acromegaly Patients: A Systematic Review and Meta-Analysis.
    Broersen LHA; Zamanipoor Najafabadi AH; Pereira AM; Dekkers OM; van Furth WR; Biermasz NR
    J Clin Endocrinol Metab; 2021 Jan; 106(2):577-587. PubMed ID: 33245343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.